Effect of alcohol intake on human apolipoprotein A-I-containing lipoprotein subfractions.
暂无分享,去创建一个
[1] S. Strasberg,et al. Lectin binding characteristics of a cholesterol nucleation promoting protein. , 1989, Clinica chimica acta; international journal of clinical chemistry.
[2] H. Keen,et al. The relationship of high density lipoprotein subfractions to alcohol consumption, other lifestyle factors, and coronary heart disease. , 1988, Atherosclerosis.
[3] J. Fruchart,et al. Apolipoprotein A-I containing lipoproteins in coronary artery disease. , 1987, Atherosclerosis.
[4] G. Anantharamaiah,et al. Characterization of high density lipoprotein subspecies: structural studies by single vertical spin ultracentrifugation and immunoaffinity chromatography. , 1987, Journal of lipid research.
[5] D. Galton,et al. High Density Lipoprotein Subfractions and Coronary Risk Factors in Normal Men , 1987, Arteriosclerosis.
[6] J. Fruchart,et al. Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles. , 1987, Biochemical and biophysical research communications.
[7] J. Albers,et al. Distribution and localization of lecithin:cholesterol acyltransferase and cholesteryl ester transfer activity in A-I-containing lipoproteins. , 1986, Journal of lipid research.
[8] P. Whitehead,et al. Drinking and the prevention of coronary heart disease: findings, issues and public health policy. , 1986, Journal of studies on alcohol.
[9] R D Moore,et al. Moderate Alcohol Consumption and Coronary Artery Disease: A REVIEW , 1986, Medicine.
[10] J. Foreyt,et al. Effect of alcohol intake and exercise on plasma high-density lipoprotein cholesterol subfractions and apolipoprotein A-I in women. , 1986, The American journal of cardiology.
[11] R. DeFronzo,et al. The effect of selective beta adrenergic blockade on glucose-induced thermogenesis in man. , 1986, Metabolism: clinical and experimental.
[12] L. Beilin,et al. Effects of alcohol consumption on serum lipoprotein-lipid and apolipoprotein concentrations. Results from an intervention study in healthy subjects. , 1986, Atherosclerosis.
[13] R. Hurt,et al. Plasma lipids and apolipoprotein A-I and A-II levels in alcoholic patients. , 1986, The American journal of clinical nutrition.
[14] J. Kalbfleisch,et al. Alcohol: high density lipoproteins, apolipoproteins. , 1986, Alcoholism, clinical and experimental research.
[15] M. Taskinen,et al. Rapid decrease in high density lipoprotein subfractions and postheparin plasma lipase activities after cessation of chronic alcohol intake. , 1986, Atherosclerosis.
[16] N. Al-Muhtaseb,et al. Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction , 1986 .
[17] R. Krauss,et al. Associations of diet and alcohol intake with high-density lipoprotein subclasses. , 1985, Metabolism: clinical and experimental.
[18] C Baum-Baicker,et al. The health benefits of moderate alcohol consumption: a review of the literature. , 1985, Drug and alcohol dependence.
[19] K. Vranizan,et al. The effect of moderate alcohol intake on serum apolipoproteins A-I and A-II. A controlled study. , 1985, JAMA.
[20] P. Alaupovic,et al. Quantitative determination of human plasma apolipoprotein A-I by a noncompetitive enzyme-linked immunosorbent assay. , 1985, Clinica chimica acta; international journal of clinical chemistry.
[21] J. Fruchart,et al. Serum apolipoprotein A-II, a biochemical indicator of alcohol abuse. , 1984, Clinica chimica acta; international journal of clinical chemistry.
[22] H. Drexel,et al. Post-heparin lipolytic activities and alterations of the chemical composition of high density lipoproteins in alcohol-induced type V hyperlipidemia. , 1984, Atherosclerosis.
[23] P. Berthelot,et al. Plasma Lipoprotein and Apolipoprotein Profile in Alcoholic Patients with and without Liver Disease: On the Relative Roles of Alcohol and Liver Injury , 1984, Hepatology.
[24] C. Malmendier,et al. Plasma levels of apolipoproteins A-I, A-II and B in alcoholism. Relation to the degree of histological liver damage, and to liver function tests. , 1983, Hepato-gastroenterology.
[25] G. Assmann,et al. Quantification of high-density-lipoprotein cholesterol by precipitation with phosphotungstic acid/MgCl2. , 1983, Clinical chemistry.
[26] C. Packard,et al. Subpopulations of apolipoprotein A-I in human high-density lipoproteins. Their metabolic properties and response to drug therapy. , 1983, Biochimica et biophysica acta.
[27] D. Jacobs,et al. The effect of alcohol on serum high density lipoprotein (HDL). A controlled experiment. , 1983, Atherosclerosis.
[28] M. Taskinen,et al. High density lipoprotein subfractions and postheparin plasma lipases in alcoholic men before and after ethanol withdrawal. , 1982, Metabolism: clinical and experimental.
[29] M. Ashley. Alcohol consumption, ischemic heart disease and cerebrovascular disease. An epidemiological perspective. , 1982, Journal of studies on alcohol.
[30] J. Barboriak,et al. Abstinence-induced changes in plasma apolipoprotein levels of alcoholics. , 1981, Drug and alcohol dependence.
[31] C. Fielding,et al. Evidence for a lipoprotein carrier in human plasma catalyzing sterol efflux from cultured fibroblasts and its relationship to lecithin:cholesterol acyltransferase. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[32] B. Lewis,et al. Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. , 1981, British medical journal.
[33] G. Miller,et al. PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE , 1975, The Lancet.
[34] J. Fruchart,et al. Quantification of two different types of apolipoprotein A-I containing lipoprotein particles in plasma by enzyme-linked differential-antibody immunosorbent assay. , 1987, Clinical chemistry.
[35] G. Fex,et al. Low serum apolipoprotein A-I in acute myocardial infarction survivors with normal HDL cholesterol. , 1986, Atherosclerosis.
[36] J. Fruchart,et al. [Focus on the classification of plasma lipoproteins]. , 1985, Annales de biologie clinique.